Mabel Ng
Medical · Tujunga, CANPI 1154679546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 753 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 753 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$3K
- Novartis$2K
- AstraZeneca$1K
- GSK$1K
- Johnson & Johnson$1K
- plus $4K from 25 others
What the payments were for
- Food & beverage$15,78199%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 154 | $3,215 |
| AbbVie | 131 | $2,567 |
| Novartis | 86 | $1,719 |
| AstraZeneca(2 entities) | 53 | $1,404 |
| GSK | 80 | $1,357 |
| Johnson & Johnson(2 entities) | 55 | $1,299 |
| UCB, Inc. | 35 | $748 |
| Mallinckrodt Hospital Products Inc. | 19 | $552 |
| Aurinia Pharma U.S., Inc. | 23 | $541 |
| E.r. Squibb & Sons, L.L.C. | 22 | $432 |
| Lilly USA, LLC | 20 | $421 |
| Radius Health, Inc. | 17 | $360 |
| Pfizer | 14 | $340 |
| Fresenius Kabi USA, LLC | 7 | $180 |
| Kowa Pharmaceuticals America, Inc. | 5 | $100 |
| ANI Pharmaceuticals, Inc. | 5 | $99 |
| Hikma Pharmaceuticals USA | 5 | $99 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $71 |
| Sobi, Inc | 2 | $53 |
| Genentech USA, Inc. | 3 | $53 |
| Scilex Pharmaceuticals Inc. | 3 | $49 |
| Bioventus LLC | 2 | $35 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $25 |
| Argenx US, Inc. | 1 | $25 |
| Zimmer Biomet | 1 | $24 |
| Tonix Medicines, Inc. | 1 | $23 |
| Octapharma USA, Inc. | 1 | $23 |
| Sanofi | 1 | $20 |
| Shorla Oncology Inc. | 1 | $17 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,881 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 26 | $162,712 |
| Xeljanz XrTofacitinib Citrate | 22 | $135,280 |
| ActemraTocilizumab | 12 | $26,023 |
| Diclofenac Sodium | 78 | $15,315 |
| Hydroxychloroquine Sulfate | 240 | $5,120 |
| Diclofenac Epolamine | 12 | $4,450 |
| Lidocaine | 30 | $3,965 |
| Gabapentin | 236 | $2,557 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 101 | $2,440 |
| MethotrexateMethotrexate Sodium | 91 | $1,980 |
| Colchicine | 28 | $1,925 |
| Febuxostat | 41 | $1,450 |
| Mycophenolate Mofetil | 21 | $1,312 |
| Nitro-BidNitroglycerin | 17 | $1,009 |
| Celecoxib | 34 | $911 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $2,567 | $162,71226 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $49 | $1,92528 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 medical providers in California.
Other medical in Tujunga
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
- Cheryl KyinnSan Diego$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.